Challenges in implementing adaptive designs: comments on the viewpoints expressed by regulatory statisticians.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 16972710)

Published in Biom J on August 01, 2006

Authors

Paul Gallo1, Willi Maurer

Author Affiliations

1: Novartis Pharmaceuticals, East Hanover, NJ, USA.

Articles by these authors

Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: general concepts. Biom J (2006) 2.61

Graphical approaches for multiple comparison procedures using weighted Bonferroni, Simes, or parametric tests. Biom J (2011) 2.45

Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: applications and practical considerations. Biom J (2006) 2.16

A graphical approach to sequentially rejective multiple test procedures. Stat Med (2009) 1.71

Powerful short-cuts for multiple testing procedures with special reference to gatekeeping strategies. Stat Med (2007) 1.16

Hierarchical testing of multiple endpoints in group-sequential trials. Stat Med (2010) 1.04

Test and power considerations for multiple endpoint analyses using sequentially rejective graphical procedures. Stat Med (2011) 0.95

Adaptive designs in clinical drug development: opportunities, challenges, and scope reflections following PhRMA's November 2006 workshop. J Biopharm Stat (2007) 0.90

Type I error rate control in adaptive designs for confirmatory clinical trials with treatment selection at interim. Pharm Stat (2012) 0.83

Trimmed weighted Simes' test for two one-sided hypotheses with arbitrarily correlated test statistics. Biom J (2009) 0.80

Perspectives on the use of adaptive designs in clinical trials. Part II. Panel discussion. J Biopharm Stat (2010) 0.79

Practical guidelines for adaptive seamless phase II/III clinical trials that use Bayesian methods. Stat Med (2012) 0.77

Multiple hypotheses testing based on ordered p values--a historical survey with applications to medical research. J Biopharm Stat (2011) 0.77

Author's reply: To PMID 21837623. Biom J (2013) 0.75